LSNE Completes Acquisition of Sterile Injectables Manufacturing Facility Located in León, Spain Read more
Boehringer, OSE doses first patient in phase 1 trial of SIRPα antagonist monoclonal antibody Read more
Exclusive Interview with Dr Zisis Kozlakidis Released ahead of SMi’s Upcoming Biobanking 2019 Conference Read more
Cytovance Biologics Completes Its Second FDA Pre-Approval Inspection (PAI) of Oklahoma City, OK Facilities Read more
CymaBay Reports Topline 12-Week Data from an Ongoing Phase 2b Study of Seladelpar in Patients with NASH Read more
Theravance Biopharma and Mylan Expand YUPELRI (revefenacin) Development and Commercialization Agreement to Include China and Adjacent Territories Read more
FDA Approves Amgen And Allergan’s KANJINTI (trastuzumab-anns), A Biosimilar To Herceptin (trastuzumab) Read more